| Date Filed | Type | Description |
| 09/29/2023 |
4
| Equels Thomas K (CEO & President) has filed a Form 4 on AIM ImmunoTech Inc.|
Txns:
| Bought 22,676 shares
@ $0.441, valued at
$10k
|
|
| 08/25/2023 |
4
| Equels Thomas K (CEO & President) has filed a Form 4 on AIM ImmunoTech Inc.|
Txns:
| Bought 8,222 shares
@ $0.669, valued at
$5.5k
|
|
| 07/17/2023 |
4
| Equels Thomas K (CEO & President) has filed a Form 4 on AIM ImmunoTech Inc.|
Txns:
| Bought 16,950 shares
@ $0.59, valued at
$10k
|
|
| 01/04/2023 |
4
| Equels Thomas K (CEO & President) has filed a Form 4 on AIM ImmunoTech Inc.|
Txns:
| Bought 161,291 shares
@ $0.31, valued at
$50k
|
|
| 12/02/2022 |
4
| Equels Thomas K (CEO & President) has filed a Form 4 on AIM ImmunoTech Inc.|
Txns:
| Granted 300,000 options to buy
@ $0.41, valued at
$123k
|
|
| 07/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2022 |
4
| Equels Thomas K (CEO & President) has filed a Form 4 on AIM ImmunoTech Inc.|
Txns:
| Granted 49,020 shares
@ $1.02, valued at
$50k
|
|
| 03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 12/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/24/2021 |
4
| EQUELS THOMAS K. (CEO & President) has filed a Form 4 on AIM ImmunoTech Inc.|
Txns:
| Granted 11,627 shares
@ $1.29, valued at
$15k
|
|
| 11/23/2021 |
4
| EQUELS THOMAS K. (CEO & President) has filed a Form 4 on AIM ImmunoTech Inc.|
Txns:
| Granted 11,194 shares
@ $1.34, valued at
$15k
|
|
| 11/19/2021 |
4
| EQUELS THOMAS K. (CEO & President) has filed a Form 4 on AIM ImmunoTech Inc.|
Txns:
| Granted 10,204 shares
@ $1.47, valued at
$15k
|
|
| 11/17/2021 |
4
| EQUELS THOMAS K. (CEO & President) has filed a Form 4 on AIM ImmunoTech Inc.|
Txns:
| Granted 9,146 shares
@ $1.64, valued at
$15k
|
|
| 11/15/2021 |
4
| EQUELS THOMAS K. (CEO & President) has filed a Form 4 on AIM ImmunoTech Inc.|
Txns:
| Granted 300,000 options
@ $1.71, valued at
$513k
|
|
| 07/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2020 |
4
| EQUELS THOMAS K. (CEO) has filed a Form 4 on AIM ImmunoTech Inc.|
Txns:
| Bought 14,535 shares
@ $1.72, valued at
$25k
|
|
| 11/13/2020 |
4
| EQUELS THOMAS K. (CEO) has filed a Form 4 on AIM ImmunoTech Inc.|
Txns:
| Granted 300,000 options
@ $1.96, valued at
$588k
|
|
| 09/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2019 |
4
| EQUELS THOMAS K. (Exec.Vice Chairman/CEO/Pres.) has filed a Form 4 on AIM ImmunoTech Inc.|
Txns:
| Granted 17,960 shares
@ $0.435, valued at
$7.8k
|
|
| 12/02/2019 |
4
| EQUELS THOMAS K. (Exec.Vice Chairman/CEO/Pres.) has filed a Form 4 on AIM ImmunoTech Inc.|
Txns:
| Granted 19,531 shares
@ $0.4, valued at
$7.8k
|
|
| 11/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/31/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2019 |
4
| EQUELS THOMAS K. (Exec. Vice Chairman/CEO/Pres.) has filed a Form 4 on AIM ImmunoTech Inc.|
Txns:
| Granted 13,470 shares
@ $0.58, valued at
$7.8k
|
|
| 06/28/2019 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 06/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2019 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/21/2019 |
4
| EQUELS THOMAS K. (Exec. Vice Chairman/CEO/Pres.) has filed a Form 4 on HEMISPHERX BIOPHARMA INC|
Txns:
| Bought 29,404 shares
@ $4.03, valued at
$118.5k
|
|
| 06/18/2019 |
SC 13D/A
| Equels Thomas K. reports a 4.2% stake in Hemispherx Biopharma, Inc. |
|